IRWD(Ironwood Pharmaceuticals, Inc.) · 财务报表

IRWD(Ironwood Pharmaceuticals, Inc.) 的财务报表:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$413.75M$410.60M$442.74M$351.41M$296.15M
毛利润—————
营业利润$232.26M$250.34M−$945.43M$93.12M$98.50M
净利润$528.45M$175.06M−$1.00B$880.00K$24.02M
经营现金流$261.89M$273.76M$183.43M$103.55M$127.04M
自由现金流$261.63M$273.63M$183.15M$103.41M$127.01M
摊薄每股收益$3.21$0.96$-6.45$0.01$0.15

Ironwood Pharmaceuticals, Inc. IRWD